Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
21.35
-0.10 (-0.47%)
At close: Dec 5, 2025

Celon Pharma Market Cap

Celon Pharma has a market cap or net worth of 1.15 billion as of December 5, 2025. Its market cap has decreased by -19.13% in one year.

Market Cap
1.15B
Enterprise Value
1.14B
Revenue
225.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.35

Market Cap Chart

Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.15B, an increase of 14.69%. That is a compound annual growth rate of 1.53%.

History

DateMarket Cap% Change
Dec 5, 20251.15B-19.28%
Dec 30, 20241.42B80.47%
Dec 29, 2023789.33M10.32%
Dec 30, 2022715.51M-57.68%
Dec 30, 20211.69B-7.35%
Dec 30, 20201.82B2.14%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Diagnostyka 5.66B
NEUCA 3.70B
Synektik Spólka Akcyjna 2.37B
Voxel 1.40B
Selvita 870.05M
Ryvu Therapeutics 670.48M
Centrum Medyczne ENEL-MED 509.05M
Scope Fluidics 463.83M
Market Cap Rankings